SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor
BioNTech at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
BioNTech brings 3 presentations to SITC 2026 in Phoenix, and exhibits at Booth 1115. Its program centres on pumitamig, an antibody aimed at both PD-L1 and VEGF-A, and on immune-stimulating antibody-drug conjugates. A concrete finding is that pumitamig grips PD-L1 more tightly once it has bound VEGF-A, pulling PD-L1 into tumor cells to be broken down.
| Organization | SITC 2026 Attendance |
|---|---|
BioNTech Mainz, Germany | |
Company developing mRNA cancer vaccines, cell therapies, bispecific antibodies and antibody-drug conjugates. | Booth Exhibiting at Booth 1115 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm |
Find decision makers at BioNTech
Tell us what you sell and we’ll find the people at BioNTech most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction